Figure 7From: An evaluation of the emerging interventions against Respiratory Syncytial Virus (RSV)-associated acute lower respiratory infections in childrenThe results of Stage II CHNRI process – an expert opinion exercise assessing the potential usefulness of investment in monoclonal antibodies for passive immunization of infants against RSV. CHNRI- Child Health and Nutrition Research InitiativeBack to article page